Wu G, Mazzitelli BA, Quek AJ, Veldman MJ, Conroy PJ, Caradoc-Davies TT, et al. Tranexamic acid is an active site inhibitor of urokinase plasminogen activator. Blood Adv. 2019;3(5):729–33.
Article
CAS
Google Scholar
Levy JH. Antifibrinolytic therapy: New data and new concepts. The Lancet. 2010. https://doi.org/10.1016/S0140-6736(10)60939-7.
Article
Google Scholar
Pusateri AE, Weiskopf RB, Bebarta V, Butler F, Cestero RF, Chaudry IH, et al. Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2013;39:121–6.
Article
Google Scholar
Hofman Z, deMaat S, Hack CE, Maas C. Bradykinin: inflammatory product of the coagulation system. Clin Rev Allergy Immuno. 2016;51(2):152–61.
Article
CAS
Google Scholar
Pilbrant Å, Schannong M, Vessman J. Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol. 1981;20(1):65–72.
Article
CAS
Google Scholar
Alaifan T, Alenazy A, Wang DX, Fernando SM, Spence J, Belley-Cote E, et al. Tranexamic acid in cardiac surgery: a systematic review and meta-analysis (protocol). BMJ Open. 2019;9(9):e028585.
Article
Google Scholar
Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials. Thrombosis Res. 2009;123(5):687–96.
Article
CAS
Google Scholar
Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): Tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind placebo controlled trial. Trials. 2010;16:12.
Google Scholar
Olldashi F, Kerçi M, Zhurda T, Ruçi K, Banushi A, Traverso MS, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–322.
Article
Google Scholar
Dries DJ. Tranexamic acid: is it about time? The Lancet. 2018;391(10116):97–8.
Article
Google Scholar
Dewan Y, Komolafe EO, Mejía-Mantilla JH, Perel P, Roberts I, Shakur H. CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012;3:86.
Google Scholar
Sprigg N, Flaherty K, Appleton JP, Salman RAS, Bereczki D, Beridze M, et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;2018:16.
Google Scholar
Busse PJ, Christiansen SC. Hereditary Angioedema. N Engl J Med. 2020;382:1136–48.
Article
CAS
Google Scholar
Wintenberger C, Boccon-Gibod I, Launay D, Fain O, Kanny G, Jeandel PY, et al. Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients. Clin Exp Immunol. 2014;6:1205–8.
Google Scholar
Beauchêne C, Martins-Héricher J, Denis D, Martin L, Maillard H. Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors. Rev Med Interne. 2018;39(10):772–6.
Article
Google Scholar
Lucas-Polomeni MM, Delaval Y, Menestret P, Delaval P, Ecoffey C. Un cas de choc anaphylactique à l’acide tranexamique (Exacyl®). Ann Fr Anesth Reanim. 2004;23:607–9.
Article
Google Scholar
Bansal RA, Nicholas A, Bansal AS. Tranexamic acid: an exceedingly rare cause of anaphylaxis during anaesthesia. Case Reports Immunol. 2016;2016:1–2.
Article
Google Scholar
Imbesi S, Nettis E, Minciullo PL, Di Leo E, Saija A, Vacca A, et al. Hypersensitivity to tranexamic acid: a wide spectrum of adverse reactions. Pharm World Sci. 2010;32(4):416–9.
Article
CAS
Google Scholar
Kavanagh GM, Sansom JE, Harrison P, Warwick JA, Peachey RD. Tranexamic acid (Cyklokapron®)-induced fixed-drug eruption [4]. Br J Dermatol. 1993;128(2):229–30.
Article
CAS
Google Scholar
Li PH, Trigg C, Rutkowski R, Rutkowski K. Anaphylaxis to tranexamic acid—a rare reaction to a common drug. J Allergy Clin Immunol Pract. 2017;5(3):839–41.
Article
Google Scholar
Laguna JJ, Archilla J, Doña I, Corominas M, Gastaminza G, Mayorga C, et al. Practical guidelines for perioperative hypersensitivity reactions. J Investig Allergol Clin Immunol. 2018;28(4):216–32.
Article
CAS
Google Scholar
Garay RP, Chiavaroli C, Hannaert P. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent. Am J Ther. 2006;13(3):236–47.
Article
Google Scholar
Lewis GJ. Does ethamsylate increase the incidence of venous thrombosis? Br Med J. 1984;288(6421):899–900.
Article
CAS
Google Scholar
Symes JM, Offen DN, Lyttle JA, Blandy JP, Saintonge DMC. The Effect of Dicynene on Blood Loss during and after Transurethral Resection of the Prostate. Br J Urol. 1975;12:18.
Google Scholar
Bryant-Smith AC, Lethaby A, Farquhar C, Hickey M. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2018;4(4):249.
Google Scholar